PODCAST · health
Science For The Real World: Canadian Hematology Today
by Catalytic Health
Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Canadian Hematology Today presents robust clinical perspectives and practical insights on the treatment and management of hematologic diseases. Hosted on Acast. See acast.com/privacy for more information.
-
7
Understanding the mechanism of BTK inhibitors
Hosted on Acast. See acast.com/privacy for more information.
-
6
Strategic Sequencing in Relapsed Refractory Multiple Myeloma
Hosted on Acast. See acast.com/privacy for more information.
-
5
Prise en charge des patients atteints de LLC doublement exposée et réfractaire.
Hosted on Acast. See acast.com/privacy for more information.
-
4
Addressing the management of patients with double exposed and refractory CLL
Sponsored by Eli Lilly Hosted on Acast. See acast.com/privacy for more information.
-
3
CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection
Sponsored by Bristol Myers Squibb. Hosted on Acast. See acast.com/privacy for more information.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Canadian Hematology Today presents robust clinical perspectives and practical insights on the treatment and management of hematologic diseases. Hosted on Acast. See acast.com/privacy for more information.
HOSTED BY
Catalytic Health
Loading similar podcasts...
URL copied to clipboard!